{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:26:55Z","timestamp":1760099215960},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2002,6,19]],"date-time":"2002-06-19T00:00:00Z","timestamp":1024444800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/1471-2261-2-10","type":"journal-article","created":{"date-parts":[[2002,10,11]],"date-time":"2002-10-11T18:42:27Z","timestamp":1034361747000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Early recovery of microvascular perfusion induced by t-PA in combination with abciximab or eptifibatide during postischemic reperfusion"],"prefix":"10.1186","volume":"2","author":[{"given":"Silva","family":"Bertuglia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Giusti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2002,6,19]]},"reference":[{"key":"16_CR1","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1161\/01.CIR.76.1.173","volume":"76","author":"Golino","year":"1987","unstructured":"Golino , Maroko PR, Carew TE: Efficacy of platelet depletion in counteracting the detrimental effect of acute hypercolesterolemia on infarct size and the no-reflow phenomenon in rabbits undergoing coronary artery occlusion-reperfusion. Circulation. 1987, 76: 173-","journal-title":"Circulation"},{"key":"16_CR2","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1182\/blood.V94.11.3829","volume":"94","author":"S Massberg","year":"1999","unstructured":"Massberg S, Enders G, de Melo-Matos FC, LID Tomic, Leiderer R, Eisenmenger S, Messmer K, Krombach F: Fibrinogen deposition at the postischemic vessel wall promotes platelet adhesion during ischemia reperfusion in vivo. Blood. 1999, 94: 3829-","journal-title":"Blood"},{"key":"16_CR3","first-page":"G1432","volume":"281","author":"W Salter","year":"2001","unstructured":"Salter W, Krieglstein CF, Issekutz AC, Granger DN: Platelets modulate ischemia reperfusion-induced leukocyte recruitment in the mesenteric circulation. Am J Physiol. 2001, 281: G1432-","journal-title":"Am J Physiol"},{"key":"16_CR4","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1007\/s001250100025","volume":"44","author":"S Bertuglia","year":"2001","unstructured":"Bertuglia S, Giusti A, Fedele S, Picano E: Glucose-insulin-potassium treatment in combination with dipyridamole inhibits ischemia-reperfusion-induced damage. Diabetologia. 2001, 44: 2165-2170. 10.1007\/s001250100025.","journal-title":"Diabetologia"},{"key":"16_CR5","first-page":"135","volume":"19","author":"NS Cook","year":"1994","unstructured":"Cook NS, Kottirsch G, Zerwes HG: Platelet glycoproteins IIb\/IIIa antagonists. Drugs of the future. 1994, 19: 135-159.","journal-title":"Drugs of the future"},{"key":"16_CR6","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1056\/NEJM199404073301402","volume":"330","author":"The EPIC Investigators","year":"1994","unstructured":"The EPIC Investigators: Use of a monoclonal antibody directed against the platelet glycoprotein IIb\/IIa receptor in high-risk coronary angioplastly: The EPIC investigation. N Engl J Med. 1994, 330: 956-10.1056\/NEJM199404073301402.","journal-title":"N Engl J Med"},{"key":"16_CR7","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1161\/01.CIR.94.9.2083","volume":"94","author":"SP Schulman","year":"1996","unstructured":"Schulman SP, Goldschmidt-Clennont PJ, Topol EJ: Effects of Integrilin a platelet glycoprotein IIb\/IIa receptor antagonist in unstable angina, a multicenter trial. Circulation. 1996, 94: 2083-89.","journal-title":"Circulation"},{"key":"16_CR8","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1161\/hc3101.092199","volume":"104","author":"M Lele","year":"2001","unstructured":"Lele M, Stouffer GA, et al: Eptifibatide and 7E3, but not Tirofiban, inhibit \u03b1v\u03b23 Integrin-mediated binding of smooth muscle cells to thrombospondin and prothrombin. Circulation. 2001, 104: 582-587.","journal-title":"Circulation"},{"issue":"4","key":"16_CR9","doi-asserted-by":"publisher","first-page":"629","DOI":"10.2165\/00003495-199856040-00014","volume":"56","author":"RH Foster","year":"1998","unstructured":"Foster RH, Wiseman LR: Abciximab. An update review of its use in ischaemic heart disease. Drugs. 1998, 56 (4): 629-665.","journal-title":"Drugs"},{"key":"16_CR10","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1093\/cvr\/27.3.500","volume":"27","author":"WE Rote","year":"1993","unstructured":"Rote WE, Werns SW, Davis JH, Feigen LP, Kilgore KS, Lucchesi BR: Platelet GPIIb\/IIIa receptor inhibition by SC-49992 prevents thrombosis and rethrombosis in the canine carotid artery. Cardiovasc Res. 1993, 27: 500-507.","journal-title":"Cardiovasc Res"},{"key":"16_CR11","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1016\/S0735-1097(01)01290-6","volume":"37","author":"KM Anderson","year":"2001","unstructured":"Anderson KM, Califf RM, Stone GW, Neumann FJ, Montalesot G, Miller DP, Ferguson JJ, Willerson JT, Topol EJ: Long-term mortality benefit with Abciximab in patients undergoing percutaneous coronary intervention. JACC. 2001, 37: 2059-65. 10.1016\/S0735-1097(01)01290-6.","journal-title":"JACC"},{"key":"16_CR12","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1161\/01.CIR.104.2.163","volume":"104","author":"AM Lincoff","year":"2001","unstructured":"Lincoff AM, Kereiakes DJ, Mascelli MA, Deckelbaum LI, Barnathan ES, Patel KK, Frederick B, Nakada MT, Topoll EJ: Abiciximab suppresses the rise in levels of circulating inflammatory markers after percutaneous coronary revascularization. Circulation. 2001, 104: 163-167.","journal-title":"Circulation"},{"key":"16_CR13","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/S0735-1097(01)01758-2","volume":"39","author":"SJ Brener","year":"2002","unstructured":"Brener SJ, Zeymer U, Adjey J, Vrobel TR, Ellis SG, Neuhaus KL, Juran N, Ivanc TB, Ohman EM, Strony J, Kitt M, Topol EJ: Eptifibatide and low-dose tissue plasminogen activactor in acute myocardial infarction. JACC. 2002, 39: 377-86. 10.1016\/S0735-1097(01)01758-2.","journal-title":"JACC"},{"key":"16_CR14","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1161\/hc3101.092199","volume":"104","author":"M Lele","year":"2001","unstructured":"Lele M, Stouffer GA, SaJid M, WaJih N, Stouffer GA: Eptifibatide and 7E3, but not Tirofiban, inhibit \u03b1v\u03b23 Integrilin-mediated binding of smooth muscle cells to thrombospondin and prothrombin. Circulation. 2001, 104: 582-587.","journal-title":"Circulation"},{"key":"16_CR15","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1161\/01.CIR.99.5.608","volume":"99","author":"S Goto","year":"1999","unstructured":"Goto S, Sakay H, Goto M, Ono M, Ikeda Y, Handa S, Ruggeri ZM: Enhanced shear rate-induced platelet aggregation in acute myocardial infarction. Circulation. 1999, 99: 608-11.","journal-title":"Circulation"},{"key":"16_CR16","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1182\/blood.V96.10.3322","volume":"96","author":"P Andre","year":"2000","unstructured":"Andre P, Denis CV, Ware J, Saffaripout S, Hynes R, Ruggeri M, Wagner DD: Platelets adhere to and translocate on von Willebrand factor presented by endothelium in stimulated veins. Blood. 2000, 96: 3322-30.","journal-title":"Blood"},{"key":"16_CR17","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1055\/s-0038-1647473","volume":"65","author":"DJ Binnema","year":"1991","unstructured":"Binnema DJ, Dooijewaard G, Turion NC: An analysis of the activators of single-chain urokinase-type plasminogen activator (scu-PA) in the dextran sulphate euglobulin fraction of normal plasma and of plasmas deficient in factor XII and prekallikrein. Thromb. Haem. 1991, 65: 144-148.","journal-title":"Thromb. Haem"},{"key":"16_CR18","first-page":"235","volume":"3","author":"SP Watkins","year":"2001","unstructured":"Watkins SP, de Lemos JA: Antiplatelet therapy in AMI: Combining GP IIb\/IIIa inhibition with reduced-dose fibrinolytic therapy. Curr Interv Cardiol Rep. 2001, 3: 235-43.","journal-title":"Curr Interv Cardiol Rep"},{"key":"16_CR19","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1161\/01.CIR.95.4.846","volume":"95","author":"EM Ohman","year":"1997","unstructured":"Ohman EM, Kleiman NS, Gacioch G, Worley SJ, Navetta FI, Talley JD, Anderson HV, Ellis S, Cohen G, Spriggs D, Miller M, Kereiakes D, Yakubov S, Kitt MM, Sigmon KM, Califf RM, Krucoff MW, Topol EJ: Combined accelerated tissue-plasminogen activator and platelet glycoprotein IIb\/IIIa integrin receptor blockade with Integrilin in acute myocardial infarction. Results of a randomized, placebo-controlled, dose-ranging trial. IMPACT-AMI Investigators. Circulation. 1997, 95: 793-801.","journal-title":"Circulation"},{"key":"16_CR20","first-page":"H755","volume":"278","author":"S Bertuglia","year":"2000","unstructured":"Bertuglia S, Colantuoni A: Protective effects of leukopenia and tissue plasminogen activator in microvascular ischemia-reperfusion injury. Am J Physiol. 2000, 278: H755-H761.","journal-title":"Am J Physiol"},{"key":"16_CR21","doi-asserted-by":"crossref","first-page":"15585","DOI":"10.1016\/S0021-9258(19)49576-8","volume":"267","author":"JJ Baldassarre","year":"1992","unstructured":"Baldassarre JJ, Henderson PA, Burns D, Fisher JY: Translocation of protein kinase C isozymes in thrombin stimulated human platelet. Correlation with1,2 dyacylglycerol levels. J Biol Chem. 1992, 267: 15585-92.","journal-title":"J Biol Chem"},{"key":"16_CR22","doi-asserted-by":"crossref","first-page":"H815","DOI":"10.1152\/ajpcell.1986.250.3.C406","volume":"250","author":"GM Rubanyi","year":"1986","unstructured":"Rubanyi GM, V PM: Oxygen derived free radicals, endothelium and responsiveness of vascular smooth muscle. Am J Physiol. 1986, 250: H815-21.","journal-title":"Am J Physiol"},{"key":"16_CR23","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1016\/0016-5085(94)90229-1","volume":"107","author":"KL Davenpeck","year":"1994","unstructured":"Davenpeck KL, Gauthier TW, Lefer AM: Inhibition of endothelial-derived nitric oxide promotes P-selectin expression and actions in the rat microcirculation. Gastrenter. 1994, 107: 1050-8.","journal-title":"Gastrenter"},{"key":"16_CR24","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1161\/01.CIR.65.2.248","volume":"65","author":"JD Folts","year":"1982","unstructured":"Folts JD, Gallagher K, Rowe GG: Blood flow reductions canine coronary arteries: vasospam or platelet aggregation?. Circulation. 1982, 65: 248-55.","journal-title":"Circulation"},{"key":"16_CR25","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1161\/01.ATV.17.3.528","volume":"17","author":"DU Simon","year":"1997","unstructured":"Simon DU, Xu H, Ortlepp P, Rogers C, Rao NK: 7E3 monoclonal antibody directed against the platelet glycoprotein IIb\/IIIa cross reacts with the leukocyte integrin Mac-1 and blocks adhjesion to fibrinogen and ICAM-1. Arterioscler Thromb Vasc Biol. 1997, 17: 528-35.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"16_CR26","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1161\/01.RES.74.2.336","volume":"74","author":"I Kurose","year":"1994","unstructured":"Kurose I, Anderson DC, MiYasaka M, Tamatani T, Paulson JC, Todd RF, Rusche JR, Granger DN: Molecular determinants of reperfusion-induced leukocyte adhesion and vascular protein leakage. Circul Res. 1994, 74: 336-42.","journal-title":"Circul Res"},{"key":"16_CR27","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1111\/j.1365-2141.1995.tb05581.x","volume":"90","author":"MA Haj","year":"1995","unstructured":"Haj MA, Neilly IJ, Robbie LA, Adey GD, Bennett B B: Influence of white blood cells on the fibrinolytic response to sepsis: studies of septic patients with or without severe leucopenia. Br J Haematol. 1995, 90: 541-7.","journal-title":"Br J Haematol"},{"issue":"8","key":"16_CR28","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1358\/mf.1999.21.8.794834","volume":"21","author":"B Campbell","year":"1999","unstructured":"Campbell B, Chuhran CM, Lefer DJ, Lefer AM: Cardioprotective effects of Abciximab (ReoPro) in an isolated perfused rat heart model of ischemia and reperfusion. Methods Find Exp Clin Pharmacol. 1999, 21 (8): 529-534.","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"16_CR29","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1136\/hrt.73.1.14","volume":"73","author":"K Riesenberg","year":"1998","unstructured":"Riesenberg K, Sclaeffer K, Katz A, Levy R: Inhibition of superoxide production in human neutrophils by combinations of heparin and thrombolytic agents. Br Heart J. 1998, 73: 14-19.","journal-title":"Br Heart J"},{"key":"16_CR30","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1161\/01.CIR.104.2.163","volume":"104","author":"AM Lincoff","year":"2001","unstructured":"Lincoff AM, Kereiakes DJ, Mascelli MA, Deckelbaum LI: Abciximab suppresses the rise in levels of circulatory inflammatory markers after percutaneous coronary revascularization. Circulation. 2001, 104: 163-167.","journal-title":"Circulation"},{"issue":"4","key":"16_CR31","first-page":"171","volume":"27","author":"S Yamada","year":"1996","unstructured":"Yamada S, Yamada R, Ishii A A, Ashikawa K, Kawamitsu H, Fujita K: Evaluation of tissue plasminogen activator and plasminogen activator inhibitor-I levels in acute myocardial infarction. J Cardiol. 1996, 27 (4): 171-8.","journal-title":"J Cardiol"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2261-2-10.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2261-2-10\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2261-2-10","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2261-2-10.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T16:20:30Z","timestamp":1726244430000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/1471-2261-2-10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,6,19]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2002,12]]}},"alternative-id":["16"],"URL":"https:\/\/doi.org\/10.1186\/1471-2261-2-10","relation":{},"ISSN":["1471-2261"],"issn-type":[{"type":"electronic","value":"1471-2261"}],"subject":[],"published":{"date-parts":[[2002,6,19]]},"assertion":[{"value":"21 January 2002","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2002","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2002","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"10"}}